China Universal Asset Management Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 10,893 shares of HRMY stock, worth $346,179. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,893
Previous 10,893
-0.0%
Holding current value
$346,179
Previous $366,000
0.27%
% of portfolio
0.05%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$357 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$115 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$82.8 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$79.3 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.88B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...